Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12NOVARTIS PHARM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 12084449

Drug Substance Claim :

Drug Product Claim :

Application Number : 213591

Patent Use Code : U-2813

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-11-19

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 12084449

Drug Substance Claim :

Drug Product Claim :

Application Number : 213591

Patent Use Code : U-2813

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-11-19

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 8901123

Drug Substance Claim :

Drug Product Claim :

Application Number : 213591

Patent Use Code : U-2813

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-05-20

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 8901123

Drug Substance Claim :

Drug Product Claim :

Application Number : 213591

Patent Use Code : U-2813

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-05-20

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 8420645

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213591

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-06-05

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 10596178

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213591

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-22

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 7767675

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213591

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-19

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 8420645

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213591

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-06-05

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 10596178

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213591

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-22

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

CAPMATINIB HYDROCHLORIDE

US Patent Number : 8461330

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213591

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-11-19

blank